Analysis of Differences between INA CBG’s Rates and Hospital Real Rates in Hemophilia Patients at RSUD Zainoel Abidin Banda Aceh

Sari Haslinur, Irwan Saputra, Dedy Syahrizal, Bakhtiar Bakhtiar, Said Usman

Abstract


INA CBG’s rate is system of health financing packages from government based on cased and hospital services. Real tariff are the actual costs incurred by hospitals service based to local governments. During this time there are differences between INA CBGs rated and hospital rates. Hemophilia is a high-cost disease paid by INA CBGs. The aim of this study was to analyze the differences of INA CBGs and real rates in Hemophilia Patients at RSUDZA Banda Aceh. The research used quantitative analyticmethod. Data collection was carried out by taking secondary data from visits of hemophilia patients at RSUDZA in January-Desember 2019. The study population was all hemophilia patients in RSUDZA in 2019 with purpousive random sample of 100 people. There was a significant difference between INA CBGs rated and hospital rates rates in Hemophilia Patients at RSUDZA Banda Aceh.which indicated by p-value 0,000. Differences between INA CBGs and real rates of hospital are Rp.-431.095.538 or -25%. Differences of INA CBGs rated dan real rates causes’ hospital loss, but hospital needs to re-review the calculation of more efficient service cost to improve the quality of service.


Keywords


INA CBG’s; real rates; hemophilia

Full Text:

PDF

References


Adiama T. 2004. Manajemen Administrasi Rumah Sakit Edisi kedua. Jakarta: FK UI.

Adisasmito, D. W. 2008. Kebijakan Standar Pelayanan Medik dan Diagnosis Related Group (DRG), Kelayakan Penerapannya di Indonesia.

Adiwijaya, S., Aritonang, D. V. A., and Mashud, M. 2018. Empowerment Pattern for Thalasemi Patients in Dr. Soetomo Hospital Surabaya. Budapest International Research and Critics Institute-Journal (BIRCI-Journal) (1): 289-298.

BPJS, Pedoman Pelaksanaan Jaminan Kesehatan Nasional (JKN), Jakarta: Centers for Desease Control and Prevention (CDC.Gov). Hemophilia Treatment. 2019.

Firmansyah, T. 2014. Analisis Selisih Tarif RS Dengan Tarif INA-CBG

Fitri, D. 2014. Analisis Perbedaan Rata-Rata Biaya dan Mutu Pelayanan

Gani, A. 2006. Analisis Biaya Rumah Sakit Makalah Seri Manajemen Keuangan Pelayanan Kesehatan, Jakarta

Hoffard, A.V. 2005. Hematologi: Edisi IV. Jakarta: EGC

Intersains, I. D. 2016. Koate, Octanine dan Octanate. Jakarta, Indonesia Revisi May 2016. Manufactured by : Grifols Therapeutic Inc. USA

Kementrian Kesehatan Republik Indonesia. 2014. Peraturan Menteri Kesehatan Republik Indonesia Nomor 27 Tahun 2014 Tentang Petunjuk Teknis Sistem Indonesian Case Base Groups (INA-CBG’s). Jakarta.

Made, A. and Wijaya. 2017. Perbedaan Tarif Riil dan INA CBGs Penyakit Thalasemia di Ruang Perawatan Anak RSUP Sanglah Bali Tahun 2017. Bali

Medidata, Referensi Obat MIMS. Edisi 2018. Jakarta: BIP

Padmawati, N. 2014. Analisis Perbandingan Antara Biaya Pelayanan Pasien Rawat Jalan dan Rawat Inap Berdasarkan Tarif Rumah Sakit Dengan Tarif INA_CBG Pada Program Jaminan Kesehatan Nasional Di RSU Zahirah Bulan Pelayanan Januari Hingga Mei 2014, Skripsi, Depok.

Peratuaran Menteri Kesehatan No 76 Tahun 2016 tentang Pedoman INA CBGs dalam Pelaksanaan Jaminan Kesehatan Nasional. Jakarta

Pradata, Y, I., Sarungu, J. J., and Suryantoro, A. 2020. Determinants of Savings and Community Loans in Ngawi District, 2010 - 2018 A Macro Economic Approach. Budapest International Research and Critics Institute-Journal (BIRCI-Journal) (3): 1506-1517.

Reliance, Sylvia, P. 2010. Hemofilia- Patofosiologis Klinis dan Proses Penyakit. Volume 1. Jakarta

Rizki, Ismail. 2016. Profil RSUDZA Banda Aceh RSU Zainoel Abidin. FK UNSYIAH.

Suryani, L. 2017. Perbedaan Biaya Riil Rumah Sakit dan Tarif INA CBGs Untuk Kasus Katastropik dengan Penyakit Jantung Koroner Pada Pasien Rawat Inap Peserta Jaminan Kesehatan Nasional di RSUDZA. Banda Aceh: Jukema. Vol 3(1):198-205.

World Federation of Hemophilia, World Bleeding Diosrder Registry, Data Report 2018.




DOI: https://doi.org/10.33258/birci.v3i3.1107

Article Metrics

Abstract view : 75 times
PDF - 42 times

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.